öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ°ÁÑ©

±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27

µ¼Ê¦ÐÕÃû£ºÍõ°ÁÑ©
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º79

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÆ¤·ôÐÔ²¡Ñ§
Ñо¿ÁìÓò£º miRNAÔÚÆ¤·ô¼²²¡Öеıí´ï¼°×÷Óã»ÌØÓ¦ÐÔÆ¤Ñ×µÄÁÙ´²Óë»ù´¡Ñо¿
Ñо¿ÁìÓò£º miRNAÔÚÆ¤·ô¼²²¡Öеıí´ï¼°×÷Óã»ÌØÓ¦ÐÔÆ¤Ñ×µÄÁÙ´²Óë»ù´¡Ñо¿ [ÊÕÆð]




¸öÈ˼òÊö :
Íõ°ÁÑ©£¬Å®£¬´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þҽԺƤ·ô¿Æ½ÌÊÚ£¬½ÌÑÐÊÒ¸±Ö÷ÈΣ¬Ò½Ñ§²©Ê¿£¬Ë¶Ê¿Éúµ¼Ê¦¡£ÖйúÖÐÎ÷Ò½½áºÏѧ»á±ä̬·´Ó¦×¨Î¯»áίԱ£¬ÁÉÄþÊ¡ÃâÒßѧ»áµÚÒ»½ìƤ·ôÃâÒßöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á³£ÎñίԱ¡£´ÓÊÂÆ¤·ô¿ÆÁÙ´²¡¢½Ìѧ¼°¿ÆÑй¤×÷20Ä꣬2012.09-2013.09Äê×÷Ϊ·ÃÎÊѧÕßÓÚÈðµä¿¨ÂÞÁÖ˹¿¨Ò½Ñ§Ôº·Ö×ÓҽѧÖÐÐÄÁôѧ¡£Ö÷ÒªÑо¿·½Ïò£ºmiRNAÔÚÆ¤·ô¼²²¡Öеıí´ï¼°×÷Óã»ÌØÓ¦ÐÔÆ¤Ñ×µÄÁÙ´²Óë»ù´¡Ñо¿¡£·¢±íÂÛÎÄ20ÓàÆª£¨ÆäÖÐSCIÊÕ¼µÚ1×÷Õß5ƪ£¬Í¨Ñ¶×÷Õß2ƪ£©¡£½üÄêÀ´Ö÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð2Ïʡ¡¢Êм¶¿ÎÌâ¸÷1Ï»ñµÃÖйúÖÐÎ÷Ò½½áºÏѧ»á¿ÆÑ§¼¼Êõ½±ÈýµÈ½±2Ïî¡£

¿ÆÑй¤×÷ :
´ú±íÎÄÕ£º
1. Li D#, Wang A#, Liu X, Meisgen F, Gr¨¹nler J, Botusan IR, Narayanan S, Erikci E, Li X, Blomqvist L, Du L, Pivarcsi A, Sonkoly E, Chowdhury K, Catrina SB,St?hle M, Land¨¦n NX. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest. **(8):3008-26. (# Equally contribution) (IF: 13.8)
2. Wang AX*, Land¨¦n N X. New insights into CD4+ T cells and their signature cytokines in atopic dermatitis. IUBMB Life. 2015 Aug67(8):601-610. (*Corresponding author) (IF 3.143)
3. Zhang YY#, Wang AX#£¬Xu L£¬Shen N, Zhu J, Tu CX. Characteristics of peripheral blood CD4+CD25+ regulatory T cells and related cytokines in severe atopic dermatitis. Eur J Dermatol. [accepted] (# Equally contribution) (IF: 2.526)
4. Wang A, Land¨¦n NX, Meisgen F, Lohcharoenkal W, St?hle M, Sonkoly E, Pivarcsi A. MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells. PLoS One. 20149(7):e103206. (IF 3.732)
5. Wang AX*, Qi XY. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma. IUBMB Life. 201365(9):748-58. (*Corresponding author) (*Corresponding author) (IF 3.143)
¿ÆÑÐÏîÄ¿£º
1. 2016-2017Ö÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¨¹ú¼Ê£¨µØÇø£©ºÏ×÷Óë½»Á÷ÏîÄ¿£©¡°»ùÓÚmicroRNA±í´ïÆ×Ñо¿Æ¤·ôÂýÐÔÉ˿ڵÄÖÎÁÆ¡± ÏîÄ¿Åú×¼ºÅ£º** £¨25ÍòÔª£©
2. 2014-2016Ö÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¨ÇàÄê»ù½ð£©¡°Ñо¿ÉÖÒ©ÜÕÖÎÁÆÌØÓ¦ÐÔÆ¤Ñ׵ķÖ×Ó»úÖÆ¼°Æä¶ÔƤ·ômiRNAµÄµ÷½Ú¡± ÏîÄ¿Åú×¼ºÅ£º**¡£ £¨23ÍòÔª£©
3. 2014Äê7ÔÂ-2017Äê6ÔÂÖ÷³ÖÁÉÄþÊ¡¿Æ¼¼Ìü×ÔÈ»»ù½ð¡°MiR-23a¶ÔÌØÓ¦ÐÔÆ¤Ñ×½ÇÖÊÐγÉϸ°ûµÄµ÷½Ú¼°Æä×÷ÓûúÖÆÑо¿¡± £¨**£© £¨5ÍòÔª£©
4. 2012Äê1ÔÂ-2013Äê12ÔÂÖ÷³Ö´óÁ¬ÊпÆÎ¯¿ÎÌâ¡°¸´·½ÜòÜßÌÀ¶ÔʪÕîÆ¤·ôÆÁÕϹ¦Äָܻ´×÷ÓõÄÑо¿¡± £¨2012E 15SF156£© £¨5ÍòÔª£©


Ïà¹Ø»°Ìâ/ÁÙ´² »ù´¡ ¼²²¡ ÃâÒß »ù½ð

öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú